Business Wire (press release) When Onglyza was used in combination with a sulfonylurea or with insulin (two medications known to cause hypoglycemia), the incidence of confirmed hypoglycemia was increased over that of placebo used in combination with a sulfonylurea or with insulin.
DailyFinance When Onglyza was used in combination with a sulfonylurea or with insulin (two medications known to cause hypoglycemia), the incidence of confirmed hypoglycemia was increased over that of placebo used in combination with a sulfonylurea or with insulin. and more »
Island Gazette They are: sulfonylurea , which increases insulin levels directly; DPP-4 inhibitor, which indirectly increases insulin levels by increasing the effect of a naturally occurring intestinal hormone; and GLP-1 agonist, which increases the amount of insulin ...
SYS-CON Media (press release) In a separate exploratory analysis of two-year data from a phase III trial comparing linagliptin to glimepiride, fewer people treated with the DPP-4 inhibitor linagliptin versus the sulfonylurea glimepiride experienced hypoglycemia (7.5 percent vs. 36 ... and more »
DailyFinance However, low blood sugar may occur when CYCLOSET is used in combination with certain other diabetes medications such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar (hypoglycemia) may include headache, drowsiness, weakness, ...
Medscape People are not enthusiastic about glyburide — many people think it is the sulfonylurea that no one should ever use, although I'm not sure if that's really tru...
Daily Markets (press release) RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE...
EurekAlert (press release) Of the patients taking JANUVIA® (sitagliptin), 6.8 percent experienced one or more episodes of symptomatic hypoglycemia, compared to 26.2 percent of patients taking a sulfonylurea (p ... and more »
Nursing Times Currently, GLP-1 agonists may be considered for people whose diabetes has not been controlled by standard first-line treatments, such as metformin and sulfonylurea , and who are obese (BMI above 35kg/m2). The National Institute for Health and Care ...
